| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 49,273 | 59,217 | 68,006 | | Cost of Revenue | 34,425 | 39,599 | 42,790 | | | Gross Profit | 14,848 | 19,618 | 25,216 | | | Operating Expenses | | Research Development | 10,303 | 7,097 | 7,977 | | Selling General and Administrative | 14,652 | 15,264 | 16,757 | | Non Recurring | 5,258 |
-
| 2,210 | | Others | 133 | 165 | 158 | | | | Total Operating Expenses | 30,346 |
-
| 27,102 | | | | Operating Income or Loss | (15,498) | (2,908) | (1,886) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,647 | 2,390 | 2,432 | | Earnings Before Interest And Taxes | (13,851) | (518) | 546 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (13,851) | (518) | 546 | | Income Tax Expense | 1,311 | 896 | 627 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (15,162) | (1,414) | (81) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (15,162) | (1,414) | (81) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($15,162) | ($1,414) | ($81) |
|
1.48% Nasdaq 
0.01 (0.33%) 
Income Statement
